These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Risk factors for recurrence of benign paroxysmal positional vertigo.
    Author: Tanimoto H, Doi K, Nishikawa T, Nibu K.
    Journal: J Otolaryngol Head Neck Surg; 2008 Dec; 37(6):832-5. PubMed ID: 19128712.
    Abstract:
    OBJECTIVE: To assess the results of treatment for a first episode of benign paroxysmal positional vertigo (BPPV) and risk factors for recurrence. STUDY DESIGN: Retrospective chart review of 148 BPPV patients at a tertiary care referral centre. MATERIALS AND METHODS: The canalith repositioning procedure (CRP) was performed until vertigo and nystagmus were resolved. Using multivariate logistic regression, we estimated the relationship between the rate of BPPV recurrence within 1 year and various risk factors for BPPV. RESULTS: Among the 145 patients after successful manoeuvre or spontaneous resolution, BPPV recurred in 31 patients (21%) within 1 year. Patients with recurrent BPPV in the posterior semicircular canal required more CRP sessions and a longer period. The rate of BPPV recurrence in patients with endolymphatic hydrops (75%) was significantly higher than in those without (odds ratio 17; 95% confidence interval 2.9-101). Both the first episode of BPPV and recurrent BPPV affected the same ear associated with endolymphatic hydrops in all patients with this complication. CONCLUSIONS: Our data suggest that endolymphatic hydrops is a risk factor for recurrence of BPPV and that prevention of recurrent BPPV is important for control of endolymphatic hydrops.
    [Abstract] [Full Text] [Related] [New Search]